Covid-19: The management of testing is evolving

The improved health situation linked to the COVID-19 outbreak in France allows the testing strategy to be adapted.

100% of Covid testing coverage by Health Insurance for all vaccinees ends on 1^er March 2023.

The February 27, 2023 order limits the list of people for whom Covid-19 testing is fully covered by Social Security.

From 1^er March 2023, screening tests (antigens, RT-PCR) are paid without a medical prescription with the introduction of user fees (co-payments), except for certain people who receive 100% care:

• persons recognized as having a long-term illness (LTD);
• persons aged 65 years and over;
• minors;
• healthcare professionals and their employees and persons working in a healthcare establishment or in a social or medico-social service, provided that they attestation on honor justifying their function;
• immunocompromised persons, for antibody testing;
• persons undergoing organized group screening.

The insured person’s co-payment is determined according to the health professional issuing the test. The insured person will have to pay 30% of the cost of the test if it is performed by a doctor or pharmacist and 40% if it is performed by a nurse or a physical therapist. If you receive a health supplement (mutual) or the solidarity health supplement, the user fee for the Covid-19 tests is fully reimbursed.

These new arrangements apply in mainland France and in all overseas departments and regions: Guadeloupe, French Guiana, Martinique, Réunion and Mayotte.